Skip to main content
. 2011 Jul 18;16(3):263–269. doi: 10.1111/j.1542-474X.2011.00441.x

Table 1.

Clinical Characteristics and Parameters between the Three Groups

RVOT‐VT ARVD BrS (n = 20) ARVD (n = 10) BrS (n = 10) P‐Value
Age (y/o)  49.4 ± 13.0  48.4 ± 11.1  41.9 ± 16.9 0.360
Male 8 4 10 0.006
RVD 26.6 ± 3.3 47.2 ± 6.2 29.6 ± 5.1 <0.001 
LVEF 67.6 ± 6.4  48.4 ± 12.6 67.0 ± 7.6 <0.001 
Family history 0 2 3 0.569
Syncope 5 2 4 0.569
SAECG
 f‐QRS (ms) 106.6 ± 7.7  137.1 ± 23.6 121.1 ± 22.2 <0.001 
 RMS40 (μV) 19.2 ± 7.6  6.3 ± 3.2  15.8 ± 16.1 0.006
 LAS40 (ms) 31.0 ± 5.7  60.4 ± 21.6  43.4 ± 18.8 <0.001 
 LP 0 10 7 <0.001 
WTECG
 P20 1082.0 ± 99.2  1000.6 ± 123.7 1082.5 ± 83.9  0.107
 P50  805.2 ± 100.1  730.0 ± 147.6  851.0 ± 111.0 0.074
 P80 450.8 ± 67.1 546.7 ± 69.2 704.6 ± 38.3 <0.001 
 P100 301.4 ± 88.6 566.4 ± 77.4 501.4 ± 81.2 <0.001 
 P150 161.2 ± 56.3  570.0 ± 124.6 297.5 ± 83.9 <0.001 

Data are given as the mean ± standard deviation, number of patients and percent of the number in parentheses. RVOT‐VT = right ventricular outflow tract ventricular tachycardia; ARVC = arrhythmogenic right ventricular cardiomyopathy; BrS = Brugada syndrome; RVD = right ventricular diameter; WTECG = wavelet‐transformed ECG; SAECG = signal‐averaged ECG; f‐QRS = filtered QRS; RMS40= root mean square voltage of the terminal 40 ms; LAS40= low‐amplitude signals <40 μV; LP = late potentilal.